Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
Conditions: Metabolic Dysfunction-associated Fatty Liver Disease; Cirrhosis Interventions: Drug: Pioglitazone metformin tablets; Drug: Other drugs; Other: Drug-free Sponsors: The Affiliated Hospital of Hangzhou Normal University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actos | Cirrhosis | Fatty Liver Disease (FLD) | Fortamet | Hospitals | Liver | Liver Disease | Metformin | Research | Study | Urology & Nephrology